On Monday, Zai Lab Limited ADR (NASDAQ: ZLAB) was 3.48% up from the session before settling in for the closing price of $30.14. A 52-week range for ZLAB has been $16.01 – $39.77.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 98.38% over the last five years. When this article was written, the company’s average yearly earnings per share was at 44.55%. With a float of $108.40 million, this company’s outstanding shares have now reached $108.42 million.
The firm has a total of 1869 workers. Let’s measure their productivity. In terms of profitability, gross margin is 63.45%, operating margin of -64.09%, and the pretax margin is -60.26%.
Zai Lab Limited ADR (ZLAB) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Zai Lab Limited ADR stocks. The insider ownership of Zai Lab Limited ADR is 1.31%, while institutional ownership is 50.53%. The most recent insider transaction that took place on Jun 02 ’25, was worth 288,540. Before that another transaction happened on May 13 ’25, when Company’s Chairperson & CEO sold 50,000 for $28.57, making the entire transaction worth $1,428,650. This insider now owns 479,851 shares in total.
Zai Lab Limited ADR (ZLAB) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 44.55% per share during the next fiscal year.
Zai Lab Limited ADR (NASDAQ: ZLAB) Trading Performance Indicators
You can see what Zai Lab Limited ADR (ZLAB) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.09. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.50, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach 0.35 in one year’s time.
Technical Analysis of Zai Lab Limited ADR (ZLAB)
Analysing the last 5-days average volume posted by the [Zai Lab Limited ADR, ZLAB], we can find that recorded value of 0.9 million was lower than the volume posted last year of 1.06 million. As of the previous 9 days, the stock’s Stochastic %D was 36.35%. Additionally, its Average True Range was 1.51.
During the past 100 days, Zai Lab Limited ADR’s (ZLAB) raw stochastic average was set at 46.21%, which indicates a significant decrease from 62.48% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.65% in the past 14 days, which was lower than the 70.16% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $31.54, while its 200-day Moving Average is $28.02. Now, the first resistance to watch is $31.85. This is followed by the second major resistance level at $32.51. The third major resistance level sits at $33.81. If the price goes on to break the first support level at $29.90, it is likely to go to the next support level at $28.60. Now, if the price goes above the second support level, the third support stands at $27.94.
Zai Lab Limited ADR (NASDAQ: ZLAB) Key Stats
There are 110,328K outstanding shares of the company, which has a market capitalization of 3.43 billion. As of now, sales total 398,990 K while income totals -257,100 K. Its latest quarter income was 106,490 K while its last quarter net income were -48,440 K.
